The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering

Published:2017-04-13 Issue:1 Volume:7 Page:21-34
ISSN:2228-5881
Container-title:Advanced Pharmaceutical Bulletin
language:en
Short-container-title:Adv Pharm Bull

Author:

Mohajeri Abbas,Sanaei Sarvin,Kiafar Farhad,Fattahi Amir,Khalili Majid,Zarghami Nosratollah

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

Link

http://journals.tbzmed.ac.ir/APB/Manuscript/APB-7-21.pdf

Reference101 articles.

1. Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action

2. Tumour Angiogenesis and Angiogenic Inhibitors: A Review

3. Novel endogenous angiogenesis inhibitors and their therapeutic potential

4. Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Cell Penetrating Peptides for Intracellular Delivery of Endostatin: A Computational Approach;Current Computer-Aided Drug Design;2024-06

2. Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights;Biomedicines;2024-04-09

3. Pre-clinical Efficacy and Safety Pharmacology of PEGylated Recombinant Human Endostatin;Current Molecular Medicine;2024-03

4. Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies;Biomedicines;2023-02-27

5. Combination Therapy in Cancer: Doxorubicin in Combination with an Nterminal Peptide of Endostatin Suppresses Angiogenesis and Stimulates Apoptosis in the Breast Cancer;INT J MOL CELL MED;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3